Novartis Ag (NVSEF) Net Margin Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) Net Margin Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 1,208.00
Jun 30, 2024 -918.00
Dec 31, 2023 1,226.00
Jun 30, 2023 10.00
Mar 31, 2023 1,709.00
Dec 31, 2022 -19,451.00
Sep 30, 2022 -20,192.00
Jun 30, 2022 -293.00
Dec 31, 2021 749.00
Sep 30, 2021 172.00
Jun 30, 2021 -32,514.00
Mar 31, 2021 -9.79 Bn
Dec 31, 2020 202,544.00
Sep 30, 2020 -5,724,137.93 Bn
Jun 30, 2020 3,141.00
Mar 31, 2020 -26,483.00
Jun 30, 2019 18,514.00
Mar 31, 2019 -66,226.00
Dec 31, 2018 -7,843.00
Jun 30, 2018 979.00